Issuer: Novo Nordisk Finance (Netherlands) B.V.
Guarantor: Novo Nordisk A/S
Amount: EUR 1,300 million
Coupon: 3.375%
Issue date: 21 May 2024
Maturity date: 21 May 2026
ISIN: XS2820449945
___________________________________________________________
Issuer: Novo Nordisk Finance (Netherlands) B.V.
Guarantor: Novo Nordisk A/S
Amount: EUR 1,000 million
Coupon: 3.125%
Issue date: 21 May 2024
Maturity date: 21 January 2029
ISIN: XS2820454606
___________________________________________________________
Issuer: Novo Nordisk Finance (Netherlands) B.V.
Guarantor: Novo Nordisk A/S
Amount: EUR 1,000 million
Coupon: 3.250%
Issue date: 21 May 2024
Maturity date: 21 January 2031
ISIN: XS2820455678
___________________________________________________________
Issuer: Novo Nordisk Finance (Netherlands) B.V.
Guarantor: Novo Nordisk A/S
Amount: EUR 1,350 million
Coupon: 3.375%
Issue date: 21 May 2024
Maturity date: 21 May 2034
ISIN: XS2820460751
___________________________________________________________
Issuer: Novo Nordisk Finance (Netherlands) B.V.
Guarantor: Novo Nordisk A/S
Amount: EUR 650 million
Coupon: 0%
Issue date: 4 June 2021
Maturity: 4 June 2024
ISIN: XS2348030268
___________________________________________________________
Issuer: Novo Nordisk Finance (Netherlands) B.V.
Guarantor: Novo Nordisk A/S
Amount: EUR 650 million
Coupon: 0.125%
Issue date: 4 June 2021
Maturity: 4 June 2028
ISIN: XS2348030425
___________________________________________________________
Issuer: Novo Nordisk Finance (Netherlands) B.V.
Guarantor: Novo Nordisk A/S
Amount: EUR 500 million
Coupon: 0.75%
Issue date: 31 March 2022
Maturity: 31 March 2025
ISIN: XS2441244535
___________________________________________________________
Issuer: Novo Nordisk Finance (Netherlands) B.V.
Guarantor: Novo Nordisk A/S
Amount: EUR 500 million
Coupon: 1.125%
Issue date: 31 March 2022
Maturity: 30 September 2027
ISIN: XS2449330179
___________________________________________________________
Issuer: Novo Nordisk Finance (Netherlands) B.V.
Guarantor: Novo Nordisk A/S
Amount: EUR 500 million
Coupon: 1.375%
Issue date: 31 March 2022
Maturity: 31 March 2030
ISIN: XS2441247041
Moody's Investors Service
Long-term: A1
Outlook: Positive
S&P Global Ratings
Long-term: AA-
Outlook: Stable
On 20 May 2021, Novo Nordisk A/S established a Euro Medium Term Note programme (the “Programme”) listed on the Euronext Dublin Regulated Market of the Irish Stock Exchange. On 9 May 2024, Novo Nordisk A/S updated the Euro Medium Term Note programme (the “Programme”) listed on the Euronext Dublin Regulated Market of the Irish Stock Exchange. As part of the update, the Programme was increased from EUR 10bn to EUR 20bn.
You are not required to provide us with your personal data. If you do not want Novo Nordisk to use your personal data, we will not be able to respond to your request.
- Contact information (name, address, telephone number, email address)
- Data concerning your health
By law, we are allowed to process your personal data if:
- you gave consent for us to process your personal data. In our contact forms you have to accept this notice to be able to submit your request.
- The processing can be necessary for our
compliance with a legal obligation depending on the type of data you
provide
- Public authorities
- Suppliers or vendors that assist our company (e.g., customer services, consultants, IT service providers, financial institutions, law firms)
The level of data protection in certain countries outside the EEA does not conform to the level of data protection for personal data currently applied and enforced within the EEA.
We therefore use the following safeguards, as required by law, to protect your personal data in case of such transfers:
- The transfer is to a Novo Nordisk entity covered by Novo Nordisk’s Binding Corporate Rules, available here.
- The destination countries are deemed by the EU Commission to have an adequate level of protection of personal data
- We have entered into Standard Contractual Clauses for the Transfer of Personal Data to Third Countries. You can get a copy of the Clauses by contacting us as described in the top of this page;
For as long as needed to provide you with the services requested by you or for as long as required by applicable law.
- You can get an overview of what personal data we have about you
- You can get a copy of your personal data in a structured, commonly used and machine-readable format
- You can get an update or correction to your personal data
- You can have your personal data deleted or destroyed
- You can have us stop or limit processing of your personal data
- If you have given consent for us to process your personal data (see Section 5), you can withdraw your consent at any time. Your withdrawal will not affect the lawfulness of the processing carried out before you withdrew your consent
- You can submit a complaint about how
we process your personal data to a Data Protection Authority.
Under applicable law, there may be limits on these rights depending on the specific circumstances of the processing activity. Contact us if you have questions or requests relating to these rights.
Investors
Share price
{{priceData.date}} {{priceData.time}}
